CLINICAL IMPACT OF ADDING PEMBROLIZUMAB TO STANDARD OF CARE CHEMORADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Category Primary study
JournalNeuro-Oncology
Year 2023
This article has no abstract
Epistemonikos ID: b4582ebdc86dafc0b2d65d4687a39ddd3ced7b8a
First added on: Feb 17, 2025